Performance of Junctional Tourniquets in Normal Human Volunteers
NCT01965561 is a phase 4 interventional trial sponsored by United States Army Institute of Surgical Research. As of 21 Nov 2026, it is completed. It studies Hemorrhage. The registry lists an enrollment of 10 participants at 1 site in 1 country. The registry lists a start date of 31 Oct 2013 and a primary completion date of 31 Dec 2013.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT01965561 |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional trial |
| Lead sponsor | United States Army Institute of Surgical Research |
| Enrollment | 10 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | Hemorrhage |
| Start | 31 Oct 2013 |
| Primary completion | 31 Dec 2013 |
| Study completion | 31 Dec 2013 |
| Last update posted | 13 Dec 2017 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- John F Kragh, MD
United States Army Institute of Surgical Research
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- United States Army Institute of Surgical Research
Forts Sam Houston
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT01965561
Each answer restates registry values shown on this page.
What is NCT01965561?
NCT01965561 is a phase 4 interventional trial sponsored by United States Army Institute of Surgical Research. It studies Hemorrhage.
Who leads NCT01965561?
The registry names John F Kragh, MD (principal investigator, United States Army Institute of Surgical Research) as the overall official.
Where does NCT01965561 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When did NCT01965561 end?
The registry lists a primary completion date of 31 Dec 2013 and a study completion date of 31 Dec 2013. The sponsor last updated the record on 13 Dec 2017.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.